__timestamp | Insmed Incorporated | PTC Therapeutics, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 33534999 | 79838000 |
Thursday, January 1, 2015 | 1982000 | 121816000 |
Friday, January 1, 2016 | 2438000 | 117633000 |
Sunday, January 1, 2017 | 2901000 | 4577000 |
Monday, January 1, 2018 | 2423000 | 12670000 |
Tuesday, January 1, 2019 | 24212000 | 12135000 |
Wednesday, January 1, 2020 | 39872000 | 18942000 |
Friday, January 1, 2021 | 44152000 | 32328000 |
Saturday, January 1, 2022 | 55126000 | 44678000 |
Sunday, January 1, 2023 | 65573000 | 65486000 |
Unleashing the power of data
In the ever-evolving landscape of biotechnology, understanding cost structures is crucial. From 2014 to 2023, Insmed Incorporated and PTC Therapeutics, Inc. have shown distinct trajectories in their cost of revenue. Insmed's cost of revenue surged by approximately 95% over this period, reflecting its strategic investments in research and development. In contrast, PTC Therapeutics experienced a more volatile path, with a notable peak in 2015, where costs were nearly 150% higher than in 2017. This fluctuation highlights the challenges and opportunities within the biotech sector. By 2023, both companies converged, with costs nearing $65 million, underscoring a competitive equilibrium. These insights not only reveal the financial dynamics of these firms but also provide a lens into the broader industry trends, where innovation and cost management are pivotal for success.
Explore the dynamic cost trends of leading biotech firms over the past decade.
Gilead Sciences, Inc. vs Insmed Incorporated: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Regeneron Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Biogen Inc. vs PTC Therapeutics, Inc.
Analyzing Cost of Revenue: Neurocrine Biosciences, Inc. and PTC Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Insmed Incorporated vs Jazz Pharmaceuticals plc
Cost of Revenue: Key Insights for Exelixis, Inc. and PTC Therapeutics, Inc.
Cost of Revenue Comparison: Telix Pharmaceuticals Limited vs PTC Therapeutics, Inc.
Cost of Revenue Trends: Ionis Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.
Cost of Revenue Comparison: PTC Therapeutics, Inc. vs Xenon Pharmaceuticals Inc.
Analyzing Cost of Revenue: PTC Therapeutics, Inc. and ACADIA Pharmaceuticals Inc.
Cost of Revenue Trends: PTC Therapeutics, Inc. vs Ligand Pharmaceuticals Incorporated
Analyzing Cost of Revenue: PTC Therapeutics, Inc. and MiMedx Group, Inc.